A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2004
12/22/2004	EP1488808A1 Remedies for glomerular diseases
12/22/2004	EP1488807A1 Remedies for sex hormone-dependent disease
12/22/2004	EP1488799A2 Soluble lymphotosin-Beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
12/22/2004	EP1488796A1 Ameliorant for chemical treatment of cancer
12/22/2004	EP1488795A1 Remedies for lung cancer
12/22/2004	EP1488794A2 Methods of contraception
12/22/2004	EP1488793A1 PREVENTIVES OR REMEDIES FOR DISEAES CAUSED BY eNOS EXPRESSION
12/22/2004	EP1488792A2 Quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
12/22/2004	EP1488791A2 Antimalarial agents
12/22/2004	EP1488790A1 Solid preparation containing single crystal form
12/22/2004	EP1488789A1 Eye drops containing tetrazole derivative
12/22/2004	EP1488788A1 Pharmaceutical combinations and their use in treating gastrointestinal disorders
12/22/2004	EP1488787A1 Topical stabilized formulations containing ketoprofen
12/22/2004	EP1488786A1 Melt-extruded orally administrable opioid formulations
12/22/2004	EP1488785A1 Oil emulsion for postnatal substitution of hormones
12/22/2004	EP1488784A1 Male contraceptive implant
12/22/2004	EP1488761A1 Device for delivering a therapeutic agent to a blood vessel
12/22/2004	EP1488699A1 Synergistic microbicidal combinations
12/22/2004	EP1488698A1 Compositions for descreasing intracellular inositol trisphosphate concentration and uses thereof
12/22/2004	EP1488239A2 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
12/22/2004	EP1488005A1 Histone deacetylase: novel molecular target of neurotoxicity
12/22/2004	EP1487998A2 Methods for diagnosing and treating schizophrenia
12/22/2004	EP1487992A2 Central airway administration for systemic delivery of therapeutics
12/22/2004	EP1487983A2 Prevention of recurrence and metastasis of cancer
12/22/2004	EP1487981A2 Growth regulating proteins
12/22/2004	EP1487903A1 Supercritical fluid extraction of vitreoretinal silicone tamponades
12/22/2004	EP1487877A2 Compositions and methods for the diagnosis and treatment of tumor
12/22/2004	EP1487857A1 Lymphatic and blood endothelial cell genes
12/22/2004	EP1487855A2 Method of using modified oligonucleotides for hepatic delivery
12/22/2004	EP1487852A1 Anti-protozoal vaccine
12/22/2004	EP1487843A2 Substituted phenylacetic acids
12/22/2004	EP1487842A1 An optically acitve pyridine derivative and a medicament containing the same
12/22/2004	EP1487841A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
12/22/2004	EP1487840A1 Crystalline polymorphic form of irinotecan hydrochloride
12/22/2004	EP1487836A1 Ethane-1,2-diamino-bis (2r)-2-bromo-3-phenylpropanoate], method for production and use thereof
12/22/2004	EP1487835A1 Amides of acetic and propionic acids
12/22/2004	EP1487834A1 Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor
12/22/2004	EP1487832A1 Micronized crystalline tiotropium bromide
12/22/2004	EP1487831A1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs
12/22/2004	EP1487830A1 Novel crystalline form of 5-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)benzyl)thiazolidine-2,4-dione potassium salt
12/22/2004	EP1487829A1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain
12/22/2004	EP1487828A2 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
12/22/2004	EP1487827A1 Anti-inflammatory morpholin-acetamide derivatives
12/22/2004	EP1487825A1 Process to obtain dibenzylbutyrolactonic lignans; process to obtain synthetic derivatives from lignanes bearing anti-chagas chemoprophylactic and therapeutical activities
12/22/2004	EP1487824A1 Diamino-pyrimidines and their use as angiogenesis inhibitors
12/22/2004	EP1487823A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
12/22/2004	EP1487822A2 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors
12/22/2004	EP1487821A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
12/22/2004	EP1487820A1 Crystalline forms of rabeprazole sodium
12/22/2004	EP1487819A2 Azepane derivatives and their use as atk1 inhibitors
12/22/2004	EP1487818A1 Alkylammonium salts of omeprazole and esomeprazole
12/22/2004	EP1487817A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487813A1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
12/22/2004	EP1487811A1 N-sulfonylurea apoptosis promoters
12/22/2004	EP1487810A2 4-(diarylmethyl)-1-piperazinyl derivatives
12/22/2004	EP1487807A2 New compounds
12/22/2004	EP1487806A1 4-anilino quinazoline derivatives as antiproliferative agents
12/22/2004	EP1487805A1 Pyrimidine derivatives
12/22/2004	EP1487804A2 Aminoindazole derivatives as protein-kinase inhibitors
12/22/2004	EP1487803A1 Indazoles substituted with an anti-cancerous activity
12/22/2004	EP1487802A1 Neurotensin active 2,3-diaryl-pyrazolidine derivatives
12/22/2004	EP1487801A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo[d]azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders
12/22/2004	EP1487800A1 Phenanthridinones as parp inhibitors
12/22/2004	EP1487799A1 9-aminoacridine derivatives and process for the preparation thereof
12/22/2004	EP1487798A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
12/22/2004	EP1487797A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
12/22/2004	EP1487794A1 Monocyclic aroylpyridinones as antiinflammatory agents
12/22/2004	EP1487793A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487791A1 A novel antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrol-2-yl)- methylethyl pentanoate
12/22/2004	EP1487790A1 Purified lasofoxifene and a method for purification of racemic lasofoxifene by recrystallization
12/22/2004	EP1487787A1 Derivatives and pharmaceutical compositions of n-hydroxyalkyl tetramethylcyclopropane-carboxamide, having anti-epileptic, neurological, and cns activity, and method for their preparation
12/22/2004	EP1487785A2 Novel florfenicol-type antibiotics
12/22/2004	EP1487783A2 Irreversible selective androgen receptor modulators and methods of use thereof
12/22/2004	EP1487782A1 Process for preparing nateglinide and intermediates thereof
12/22/2004	EP1487780A1 Haloacetamide and azide substituted compounds and methods of use thereof
12/22/2004	EP1487778A1 Substituted 4-aminocyclohexanols
12/22/2004	EP1487776A1 Acid and ester compounds and methods of using the same
12/22/2004	EP1487774A2 Bipolar trans carotenoid salts and their uses
12/22/2004	EP1487542A1 Use of asc-1 inhibitors to treat neurological and psychiatric disorders
12/22/2004	EP1487540A2 Storage stable eplerenone formulation
12/22/2004	EP1487539A1 Lower esophagus tissue modifier
12/22/2004	EP1487506A2 Preparation for wound healing and prevention of bandage adhesion to the wound
12/22/2004	EP1487495A1 Combination comprising a cdk inhibitor and doxorubicin
12/22/2004	EP1487494A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
12/22/2004	EP1487492A1 The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
12/22/2004	EP1487491A2 Novel of cytokine inhibitors
12/22/2004	EP1487490A2 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
12/22/2004	EP1487489A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN avb3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
12/22/2004	EP1487486A2 Imidazoquinolineamines as adjuvants in hiv dna vaccination
12/22/2004	EP1487485A2 Imidazoquinoline adjuvants for vaccines
12/22/2004	EP1487475A1 Use of enzyme inhibitors with aminopeptidase n and/or dipeptidylpeptidase iv activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states
12/22/2004	EP1487474A2 Intranasal administration of mc4-r agonists
12/22/2004	EP1487472A2 Stabilization of hypoxia inducible factor (hif) alpha
12/22/2004	EP1487471A2 Methods for treating autoimmune disorders and reagents related thereto
12/22/2004	EP1487470A1 Identification of free-b-ring flavonoids as potent cox-2 inhibitors
12/22/2004	EP1487469A1 Co-beadlet of dha and rosemary and methods of use
12/22/2004	EP1487462A2 Preparations for topical skin use and treatment
12/22/2004	EP1487461A1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes
12/22/2004	EP1487460A2 Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof
12/22/2004	EP1487459A1 Peptide analogues and uses thereof

1 ... 4851 4852 4853 4854 4855 4856 4857 4858 4859 4860 4861 4862 4863 4864 4865 4866 4867 4868 4869 4870 4871 ... 7860